This specialty practice discussion group is intended for nurse educator members of APHON. Remember that... View more
This specialty practice discussion group is intended for nurse educator members of APHON. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
In our office visit area the primary role of the LVN is to access ports, draw labs, and perform dressing changes on central lines. In the Infusion Area the RN’s perform all of those tasks if the patient isn’t already accessed from their office visit. We do not allow MA’s or phlebotomist to touch the central lines.
______________________________________________________________________ CONFIDENTIALITY NOTICE: The information in this e-mail may be confidential and/or privileged. If you are not the intended recipient or an authorized representative of the intended recipient, you are hereby notified that any review, dissemination, or copying of this e-mail and its attachments, if any, or the information contained herein is prohibited. If you have received this e-mail in error, please immediately notify the sender by return e-mail and delete this e-mail from your computer system. Thank you. ______________________________________________________________________
I have a question about who, in your respective institutions, is allowed to draw labs from the Central Lines of the Heme/Onc and Stem Cell patient population. Does your support staff draw from a central line with proper training (phlebotomists, MAs or LVNs?) or is your policy similar to ours to where only the RN can draw from the Central Lines of Pediatric Patients?
The information contained in this e-mail message may be privileged, confidential, and/or protected from disclosure. This e-mail message may contain protected health information (PHI); dissemination of PHI should comply with applicable federal and state laws. If you are not the intended recipient, or an authorized representative of the intended recipient, any further review, disclosure, use, dissemination, distribution, or copying of this message or any attachment (or the information contained therein) is strictly prohibited. If you think that you have received this e-mail message in error, please notify the sender by return e-mail and delete all references to it and its contents from your systems.